Product Code: ETC070120 | Publication Date: Jun 2021 | Updated Date: Jan 2024 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Orphan Drugs Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Orphan Drugs Market Revenues & Volume, 2020 & 2030F |
3.3 China Orphan Drugs Market - Industry Life Cycle |
3.4 China Orphan Drugs Market - Porter's Five Forces |
3.5 China Orphan Drugs Market Revenues & Volume Share, By Drugs, 2020 & 2030F |
3.6 China Orphan Drugs Market Revenues & Volume Share, By Drug Type, 2020 & 2030F |
3.7 China Orphan Drugs Market Revenues & Volume Share, By Therapy Class, 2020 & 2030F |
4 China Orphan Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 China Orphan Drugs Market Trends |
6 China Orphan Drugs Market, By Types |
6.1 China Orphan Drugs Market, By Drugs |
6.1.1 Overview and Analysis |
6.1.2 China Orphan Drugs Market Revenues & Volume, By Drugs, 2018 - 2027F |
6.1.3 China Orphan Drugs Market Revenues & Volume, By Revlimid, 2018 - 2027F |
6.1.4 China Orphan Drugs Market Revenues & Volume, By Rituxan, 2018 - 2027F |
6.1.5 China Orphan Drugs Market Revenues & Volume, By Opdivo, 2018 - 2027F |
6.1.6 China Orphan Drugs Market Revenues & Volume, By Keytruda, 2018 - 2027F |
6.1.7 China Orphan Drugs Market Revenues & Volume, By Imbruvica, 2018 - 2027F |
6.1.8 China Orphan Drugs Market Revenues & Volume, By Soliris, 2018 - 2027F |
6.2 China Orphan Drugs Market, By Drug Type |
6.2.1 Overview and Analysis |
6.2.2 China Orphan Drugs Market Revenues & Volume, By Biologics, 2018 - 2027F |
6.2.3 China Orphan Drugs Market Revenues & Volume, By Non-Biologics, 2018 - 2027F |
6.3 China Orphan Drugs Market, By Therapy Class |
6.3.1 Overview and Analysis |
6.3.2 China Orphan Drugs Market Revenues & Volume, By Oncology, 2018 - 2027F |
6.3.3 China Orphan Drugs Market Revenues & Volume, By Blood, 2018 - 2027F |
6.3.4 China Orphan Drugs Market Revenues & Volume, By Endocrine, 2018 - 2027F |
6.3.5 China Orphan Drugs Market Revenues & Volume, By Central Nervous Systems, 2018 - 2027F |
6.3.6 China Orphan Drugs Market Revenues & Volume, By Cardiovascular, 2018 - 2027F |
6.3.7 China Orphan Drugs Market Revenues & Volume, By Respiratory, 2018 - 2027F |
7 China Orphan Drugs Market Import-Export Trade Statistics |
7.1 China Orphan Drugs Market Export to Major Countries |
7.2 China Orphan Drugs Market Imports from Major Countries |
8 China Orphan Drugs Market Key Performance Indicators |
9 China Orphan Drugs Market - Opportunity Assessment |
9.1 China Orphan Drugs Market Opportunity Assessment, By Drugs, 2020 & 2030F |
9.2 China Orphan Drugs Market Opportunity Assessment, By Drug Type, 2020 & 2030F |
9.3 China Orphan Drugs Market Opportunity Assessment, By Therapy Class, 2020 & 2030F |
10 China Orphan Drugs Market - Competitive Landscape |
10.1 China Orphan Drugs Market Revenue Share, By Companies, 2020 |
10.2 China Orphan Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |